[Multi-center clinical study on the treatment of the low-middle frequency sudden hearing loss].
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
; 48(5): 362-7, 2013 May.
Article
em Zh
| MEDLINE
| ID: mdl-24016558
ABSTRACT
OBJECTIVE:
To investigate and compare the short-term outcome of patients with low-middle frequency sudden deafness treated with alone or combination treatment.METHODS:
From August 2007 to October 2011, 205 patients with the diagnosis of low-middle frequency sudden deafness who were from 33 different clinical centers were recruited. All patients were followed up for four weeks from the initial examination. Patients were treated with steroid , Ginaton, batroxobin respectively, or Ginaton and steroid combination treatment.RESULTS:
The total effective rate was 90.73%. In Ginaton group, the total effective rate was 87.27%, 89.19% in steroid group, 87.80% in batroxobin group, and 95.83% in Ginaton and steroid group. Considering the total effective rate, there was no statistical difference between four groups (χ(2) = 7.98, P = 0.54). The clinical cure rate for steroid alone was 81.01%, Ginaton alone 76.36%, batroxobin alone 68.29%, and Ginaton and steroid combination treatment 80.56%. There were no clinically significant differences between the different treatments (P > 0.05).CONCLUSIONS:
The low-middle frequency sudden deafness tends to have a relatively favorable prognosis. The steroid played a good effect in the treatment. But different treatments either improving the microcirculation of inner ear or alleviating edema blood has undifferentiated results. Therefore the combination therapy may be more effective.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Perda Auditiva Súbita
Tipo de estudo:
Clinical_trials
/
Diagnostic_studies
/
Prognostic_studies
Limite:
Humans
País como assunto:
Asia
Idioma:
Zh
Ano de publicação:
2013
Tipo de documento:
Article